OMTHERA PHARMACEUTICALS INC |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2013 | Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion | RE |
| 2013 | Novartis AG : AstraZeneca buys U.S. lung drug firm Pearl for up to $1.15 billion | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 0 | 4,694,375 | 0 | 0 | 86.94 % |
| Stock B | 0 | 21,121,044 | 18,361,784 ( 86.94 %) | 0 | |
| Stock C | 0 | 10,131,879 | 0 | 0 |
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +15.82% | 78.51B | |
| +13.10% | 9B | |
| +58.17% | 4.96B | |
| -14.94% | 4.84B | |
| -.--% | 3.72B | |
| +19.74% | 2.48B | |
| -26.63% | 2.19B | |
| +16.75% | 2.12B | |
| -37.97% | 1.94B |
- Stock Market
- Equities
- Stock
- Company Omthera Pharmaceuticals Inc
